《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元

AAFN2020-11-19

根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售获近264倍超购，已启动回拨机制占比增至50%，认购一手中签率20%；股份以招股范围(15.8-18.08元)上限定价，料集资净额约26.36亿元，主要用作分配予集团核心产品、为集团其他四个临床阶段候选药物提供资金、用於管线中其他临床前候选药物正在进行临床前研究及计划进行临床试验，以及扩大其研发管线等。上市联席保荐人分别为高盛及摩根大通。(sz/t)~阿思达克财经新闻网址: www.aastocks.com

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

不贪心的年轻人
2020-11-19
不贪心的年轻人
真准

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2084647950?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","is_english":false,"pubTime":"2020-11-19 16:17","share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","id":"2084647950","market":"us","top_or_hot":-1,"title":"《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元","media":"AAFN","content":"<html><body><p>根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售获近264倍超购，已启动回拨机制占比增至50%，认购一手中签率20%；股份以招股范围(15.8-18.08元)上限定价，料集资净额约26.36亿元，主要用作分配予集团核心产品、为集团其他四个临床阶段候选药物提供资金、用於管线中其他临床前候选药物正在进行临床前研究及计划进行临床试验，以及扩大其研发管线等。上市联席保荐人分别为<a href=\"https://laohu8.com/S/GS\">高盛</a>及<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>。(sz/t)~阿思达克财经新闻网址: www.aastocks.com\t\t\t\t\t\t\t\t\t </p></body></html>","source":"aastocks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-11-19 16:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06996","symbol_name":"德琪医药-B","start_time":0,"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","article_id":"2084647950","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2084647950","pubTimestamp":1605773868,"columns":[],"sourceInfo":{"source_id":"aastocks","name":"阿思达克财经"},"weMediaInfo":null,"summary":"根据辉立交易平台显示，明天挂牌的德琪医药暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","06996":"德琪医药-B","09939":"开拓药业-B"},"translate_title":"[Performance of New Shares] Deqi Pharmaceutical (06996. HK) closed about 9% higher at 19.7 yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"06996":1,"09939":1},"content_text":"根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售获近264倍超购，已启动回拨机制占比增至50%，认购一手中签率20%；股份以招股范围(15.8-18.08元)上限定价，料集资净额约26.36亿元，主要用作分配予集团核心产品、为集团其他四个临床阶段候选药物提供资金、用於管线中其他临床前候选药物正在进行临床前研究及计划进行临床试验，以及扩大其研发管线等。上市联席保荐人分别为高盛及摩根大通。(sz/t)~阿思达克财经新闻网址: www.aastocks.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":390631908,"gmtCreate":1605782842104,"gmtModify":1703839558952,"author":{"id":"3566897829478272","authorId":"3566897829478272","name":"不贪心的年轻人","avatar":"https://static.tigerbbs.com/62a7e4cc8a812fe1b342cee71ffafe88","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3566897829478272","authorIdStr":"3566897829478272"},"htmlText":"真准","listText":"真准","text":"真准","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/390631908","repostId":2084647950,"repostType":2,"repost":{"id":"2084647950","kind":"news","pubTimestamp":1605773868,"share":"https://www.laohu8.com/m/news/2084647950?lang=&edition=full","pubTime":"2020-11-19 16:17","market":"us","language":"zh","title":"《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2084647950","media":"AAFN","summary":"根据辉立交易平台显示，明天挂牌的德琪医药暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","content":"<html><body><p>根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售获近264倍超购，已启动回拨机制占比增至50%，认购一手中签率20%；股份以招股范围(15.8-18.08元)上限定价，料集资净额约26.36亿元，主要用作分配予集团核心产品、为集团其他四个临床阶段候选药物提供资金、用於管线中其他临床前候选药物正在进行临床前研究及计划进行临床试验，以及扩大其研发管线等。上市联席保荐人分别为<a href=\"https://laohu8.com/S/GS\">高盛</a>及<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>。(sz/t)~阿思达克财经新闻网址: www.aastocks.com\t\t\t\t\t\t\t\t\t </p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股表现》德琪医药(06996.HK)暗盘高开约9%报19.7元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-11-19 16:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","relate_stocks":{"159938":"医药","06996":"德琪医药-B","09939":"开拓药业-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1057530&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2084647950","content_text":"根据辉立交易平台显示，明天挂牌的德琪医药(06996.HK)暗盘高开约9%报19.7元，最高见20.5元遇压，最低见18.26元，现造18.5元，较上市价18.08元，高2.3%，成交89万股。德琪是一家专注於创新抗肿瘤药物的亚太地区临床阶段生物制药公司。是次上市共发售1.54亿股，并已引入包括富达、GIC、BlackRock及博裕等10名基石投资者合共认购7,690.4万股；其中10%公开发售获近264倍超购，已启动回拨机制占比增至50%，认购一手中签率20%；股份以招股范围(15.8-18.08元)上限定价，料集资净额约26.36亿元，主要用作分配予集团核心产品、为集团其他四个临床阶段候选药物提供资金、用於管线中其他临床前候选药物正在进行临床前研究及计划进行临床试验，以及扩大其研发管线等。上市联席保荐人分别为高盛及摩根大通。(sz/t)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.5","shortVersion":"4.33.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2084647950"}